Trial Profile
Pharmacokinetics, Safety, and Tolerability of Fluticasone Propionate Multidose Dry Powder Inhaler and Fluticasone Diskus® Administered in Healthy Subjects: an Open-Label, Randomized, Three-Period Crossover, Single-Dose Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 May 2015
Price :
$35
*
At a glance
- Drugs Fluticasone propionate (Primary)
- Indications Asthma
- Focus Adverse reactions; Pharmacokinetics
- 19 May 2015 Status changed from not stated to completed.
- 30 Apr 2015 New trial record